CSIMarket
 


Ispecimen inc   (ISPC)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare

Ispecimen Inc 's Tangible Leverage Ratio

ISPC's quarterly Tangible Leverage Ratio and Total Liabilities, Tangible Equity growth


Due to net new borrowings of 69.33%, Tangible Leverage Ratio fell to 0.69, above the Ispecimen Inc 's average Tangible Leverage Ratio.

Within Medical Laboratories industry in the forth quarter 2023, 7 other companies have achieved lower Tangible Leverage Ratio than Ispecimen Inc in the IV Quarter 2023. While Tangible Leverage Ratio total ranking has deteriorated compared to the third quarter 2023 from 125 to 617 .

Explain Tangible Leverage Ratio?
What is ISPC Market Share?
What are ISPC´s Total Liabilities?


ISPC Tangible Leverage Ratio (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Tangible Equity Change -56.51 % -43.34 % -41.85 % -34.64 % -31.83 %
Y / Y Total Liabilities Change 41.07 % -34.93 % -46.04 % -34.04 % -27.32 %
Tangible Leverage Ratio MRQ 0.69 0.28 0.19 0.2 0.21
ISPC's Total Ranking # 617 # 125 # 444 # 480 # 531
Seq. Tangible Equity Change -30.48 % -13.63 % -18.66 % -10.95 % -9.43 %
Seq. Total Liabilities Change 69.33 % 30.44 % -25.77 % -13.96 % -21.9 %



Tangible Leverage Ratio forth quarter 2023 Company Ranking
Within: No.
Medical Laboratories Industry # 8
Healthcare Sector # 183
Overall Market # 617


Tangible Leverage Ratio Statistics
High Average Low
0.84 0.33 0.19
(Jun 30 2021)   (Jun 30 2023)




Financial Statements
Ispecimen Inc 's Tangible Equity $ 9 Millions Visit ISPC's Balance sheet
Ispecimen Inc 's Total Liabilities $ 6 Millions Visit ISPC's Balance sheet
Source of ISPC's Sales Visit ISPC's Sales by Geography


Cumulative Ispecimen Inc 's Tangible Leverage Ratio

ISPC's Tangible Leverage Ratio for the trailling 12 Months

ISPC Tangible Leverage Ratio

(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Tangible Equity TTM Growth -56.51 % -43.34 % -41.85 % -34.64 % -31.83 %
Y / Y Total Liabilities TTM Growth 41.07 % -34.93 % -46.04 % -34.04 % -27.32 %
Tangible Leverage Ratio TTM 0.3 0.22 0.22 0.22 0.21
Total Ranking TTM # # # # #
Seq. Tangible Equity TTM Growth -30.48 % -13.63 % -18.66 % -10.95 % -9.43 %
Seq. Total Liabilities TTM Growth 69.33 % 30.44 % -25.77 % -13.96 % -21.9 %


On the trailing twelve months basis Due to the net new borrowings of 69.33% during the trailing twelve months finishing in the IV Quarter 2023, cumulativeTangible Leverage Ratio improved to 0.3, below the Ispecimen Inc 's average Tangible Leverage Ratio.
Tangible Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Medical Laboratories industry 7, during the past 12 months, other companies have achieved lower Tangible Leverage Ratio than Ispecimen Inc . While Tangible Leverage Ratio total ranking has deteriorated during the twelve months ending in the IV Quarter 2023, compared to the prior period, from 554 to 1.

Explain Tangible Leverage Ratio?
What is ISPC Market Share?
What are ISPC´s Total Liabilities?

TTM Tangible Leverage Ratio Company Ranking
Within: No.
Within the Medical Laboratories Industry # 8
Healthcare Sector # 183
Within the Market # 617


trailing twelve months Tangible Leverage Ratio Statistics
High Average Low
0.84 0.33 0.19
(Jun 30 2021)   (Jun 30 2023)




Companies with similar Tangible Leverage Ratio in the quarter ending Dec 31 2023, within Medical Laboratories Industry Tangible Leverage RatioDec 31 2023 MRQ Total LiabilitiesDec 31 2023 MRQ Tangible Equity
Exagen Inc   1.47 $ 33.274  Millions$ 22.694  Millions
Caredx Inc   1.17 $ 205.498  Millions$ 175.291  Millions
Natera inc   0.86 $ 659.760  Millions$ 765.327  Millions
Ispecimen inc   0.69 $ 6.078  Millions$ 8.833  Millions
Omniab Inc   0.67 $ 50.306  Millions$ 75.139  Millions
Butterfly Network inc   0.40 $ 84.221  Millions$ 209.736  Millions
Sera Prognostics Inc   0.36 $ 25.283  Millions$ 70.158  Millions
Enzo Biochem Inc  0.35 $ 24.655  Millions$ 70.775  Millions
Incyte Corporation  0.32 $ 1,592.270  Millions$ 4,910.699  Millions
Veracyte inc   0.25 $ 63.691  Millions$ 252.525  Millions
Absci Corp  0.22 $ 28.757  Millions$ 127.923  Millions
Castle Biosciences Inc   0.17 $ 47.692  Millions$ 273.934  Millions

Date modified: 2024-03-13T23:05:05+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com